Indias Dhampur Bio Organics falls after reporting Q3 loss - XM
| DBOL Stock | 129.11 1.36 1.06% |
Slightly above 51% of Dhampur Bio's investor base is interested to short. The analysis of overall sentiment of trading Dhampur Bio Organics stock suggests that many investors are impartial at this time. Dhampur Bio's investing sentiment can be driven by a variety of factors including economic data, Dhampur Bio's earnings reports, geopolitical events, and overall market trends.
Dhampur Bio stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Dhampur daily returns and investor perception about the current price of Dhampur Bio Organics as well as its diversification or hedging effects on your existing portfolios.
Dhampur |
Indias Dhampur Bio Organics falls after reporting Q3 loss XM
Read at news.google.com
 |
Dhampur Bio Fundamental Analysis
We analyze Dhampur Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dhampur Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dhampur Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Dhampur Bio is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Dhampur Bio Organics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dhampur Bio stock to make a market-neutral strategy. Peer analysis of Dhampur Bio could also be used in its relative valuation, which is a method of valuing Dhampur Bio by comparing valuation metrics with similar companies.
Peers
Dhampur Bio Related Equities
| 63MOONS | 63 Moons | 5.00 | ||||
| ATFL | Agro Tech | 1.86 | ||||
| MTARTECH | Mtar Technologies | 0.44 | ||||
| SPENCERS | Spencers Retail | 0.14 | ||||
| VMART | V Mart | 0.23 | ||||
| V2RETAIL | V2 Retail | 2.22 | ||||
| PYRAMID | PYRAMID TECHNOPLAST | 3.79 |
Additional Tools for Dhampur Stock Analysis
When running Dhampur Bio's price analysis, check to measure Dhampur Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dhampur Bio is operating at the current time. Most of Dhampur Bio's value examination focuses on studying past and present price action to predict the probability of Dhampur Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dhampur Bio's price. Additionally, you may evaluate how the addition of Dhampur Bio to your portfolios can decrease your overall portfolio volatility.